The current ENZN market cap is 7.01M. The company's latest EPS is USD -0.0197 and P/E is -4.57.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 6.92M | 207k | 52k | 701k | 26k |
Operating Income | 5.86M | -973k | -1.31M | -469k | -1.03M |
Net Income | 5.85M | -979k | -1.77M | -2.49M | -1.46M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 15.51M | 6.48M | 48.23M | 47.75M | 47.59M |
Total Liabilities | 517k | 423k | 412k | 403k | 1.7M |
Total Equity | 14.99M | 6.06M | 7.36M | 4.87M | 3.41M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -978k | 6.91M | -380k | -501k | -659k |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | -7.96M | 44.05M | N/A | N/A |
Market Cap | 7.01M |
Price to Earnings Ratio | -4.57 |
Price to Sales Ratio | 225 |
Price to Cash Ratio | 0.14 |
Price to Book Ratio | 0.15 |
Dividend Yield | - |
Shares Outstanding | 74.21M |
Average Volume (1 week) | 26.8k |
Average Volume (1 Month) | 37.62k |
52 Week Change | -57.72% |
52 Week High | 0.26 |
52 Week Low | 0.06 |
Spread (Intraday) | 0.11 (99.91%) |
Company Name | Enzon Inc (QX) |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.enzon.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.